Investigational Drug Information for Treosulfan
✉ Email this page to a colleague
What is the development status for investigational drug Treosulfan?
Treosulfan is an investigational drug.
There have been 40 clinical trials for Treosulfan.
The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2008.
The most common disease conditions in clinical trials are Leukemia, Myelodysplastic Syndromes, and Preleukemia. The leading clinical trial sponsors are medac GmbH, Fred Hutchinson Cancer Research Center, and National Cancer Institute (NCI).
Summary for Treosulfan
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 3,774 |
| WIPO Patent Applications | 2,418 |
| Japanese Patent Applications | 244 |
| Clinical Trial Progress | Phase 3 (2008-10-01) |
| Vendors | 42 |
Recent Clinical Trials for Treosulfan
| Title | Sponsor | Phase |
|---|---|---|
| Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia | Medexus Pharma, Inc. | Phase 2 |
| Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia | Fred Hutchinson Cancer Research Center | Phase 2 |
| Comparsion of PT-Cy at a Dose of 25 mg/kg/Day and PT-Cy at a Dose of 50 mg/kg/Day in GVHD Prophylaxis | National Research Center for Hematology, Russia | Phase 3 |
Clinical Trial Summary for Treosulfan
Top disease conditions for Treosulfan
Top clinical trial sponsors for Treosulfan
US Patents for Treosulfan
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
